Richard Crowley, EVP, Biopharmaceutical Operations at SAVIENT PHARMACEUTICALS INC (SVNT), sold 2,415 shares at $1.02 ($2K) on 2013-01-31, disclosed to the SEC on 2013-02-04.
Scheduled sale ($2k) by EVP, Biopharmaceutical Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SVNT | SELL | 2013-02-06 | $51K | — | Filing → |
| SVNT | SELL | 2012-11-06 | $3K | — | Filing → |
| SVNT | SELL | 2012-08-03 | $2K | — | Filing → |